Tissue factor pathway inhibitor promotes the migration, proliferation and colonization of MSCs by regulating

Miao Li1, Dongze Qiu2, Yufan Li1

  • 1Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

Insights

Tissue factor pathway inhibitors (TFPI) enhance mesenchymal stem cell (MSC) migration and homing, improving lung injury recovery. TFPI regulates the CXCL12/CXCR4 pathway, boosting MSC colonization and function in lung injury models.

Area of Science:

  • Regenerative Medicine
  • Cell Biology
  • Pulmonary Medicine

Background:

  • Mesenchymal stem cells (MSCs) show therapeutic potential for lung injury but suffer poor retention at injury sites.
  • Tissue factor pathway inhibitors (TFPI) are known to enhance stem/progenitor cell migration and homing.
  • Combining MSCs with TFPI may overcome MSC retention limitations in lung injury treatment.

Purpose of the Study:

  • To evaluate the efficacy of combining TFPI with MSCs for treating lung injury.
  • To investigate the underlying mechanisms by which TFPI influences MSC behavior and lung repair.
  • To explore the role of the CXCL12/CXCR4 signaling pathway in TFPI-mediated MSC homing.

Main Methods:

  • Lipopolysaccharide (LPS)-induced acute lung injury (ALI) mouse model treated with rhTFPI and/or MSCs.
  • Assessment of lung histology, coagulation function, inflammatory markers (TNF-α, IL-1β), and cell colonization.
  • In vitro assays for MSC migration, viability, and proliferation; RNA sequencing for gene expression analysis.
  • Genetic manipulation of MSCs to overexpress or knockdown TFPI.

Main Results:

  • Combined rhTFPI and MSC treatment significantly improved lung injury recovery and survival rates.
  • rhTFPI enhanced MSC viability, proliferation, and migration, promoting better colonization in lung injury sites.
  • RNA sequencing revealed CXCL12 as a key upregulated gene, suggesting its involvement in the therapeutic mechanism.
  • TFPI levels modulated MSC migration, proliferation, and colonization, correlating with CXCL12/CXCR4 pathway activity.

Conclusions:

  • TFPI combined with MSCs offers a promising strategy for enhancing lung injury repair.
  • TFPI promotes MSC migration, proliferation, and homing, potentially by regulating the CXCL12/CXCR4 signaling pathway.
  • This study elucidates a novel mechanism for improving stem cell therapy efficacy in lung injury.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K